Little evidence that breast cancer diagnosis leads to employment discrimination, study concludes

December 14, 2004

Women diagnosed with breast cancer are no more likely than women in the general population to experience discrimination at work, according to a new study in the December 15 issue of the Journal of the National Cancer Institute.

Despite legislation in Canada and other countries to protect workers from discrimination based on disability or health state, some cancer survivors have reported problems in the workplace after cancer. These problems have included job loss, demotion, decreased wages, difficulty in obtaining a new job, and problems with supervisors and colleagues. However, few quantitative studies have addressed the work experiences of cancer survivors.

To assess breast cancer survivors' work experience, Elizabeth Maunsell, of the Université Laval in Quebec City, and colleagues conducted a population-based retrospective cohort study in Quebec, Canada, of a series of breast cancer patients who were age 60 and younger at diagnosis. The work experiences of 646 of these women over the 3 years after their diagnosis were compared with the experiences during the same time period of a group comprised of 890 women who were similar to the survivors except that they had never been diagnosed with cancer.

Slightly more breast cancer survivors than women in the comparison group (21% versus 15%) were unemployed at the end of the 3-year period. However, most women who were not working (84% of unemployed survivors and 76% of unemployed women in the comparison group) said that the decision to stop working was their own. Among women still employed 3 years later, no deterioration in working conditions was observed in either group. In addition, negative events, such as firings, were rare in both groups.

"[W]e recognize that individual women may find the return to work after breast cancer difficult and may attribute work problems or the personal decision to reduce work effort to the fact of having had breast cancer," the authors write. "On a population basis, however, we found little evidence to support the idea of involuntary changes in work situation because of breast cancer in Quebec. Thus, we believe that these results should provide some reassurance for working women who have just been diagnosed with breast cancer, especially women who are part of health and social systems similar to those in Canada."

In an editorial, Leslie R. Schover, Ph.D., of the University of Texas M. D. Anderson Cancer Center in Houston, discusses how most stereotypes of breast cancer survivorship have proven to be untrue. For example, breast cancer does not lead to higher divorce rates, and the type of breast surgery plays little role in a woman's sexual function or satisfaction. "We should, however, not grow complacent about, nor should we trivialize, the emotional and physical pain of acute cancer treatment," she writes. "However, future research on breast cancer survivorship should focus on those women who may be at increased risk for poor psychosocial outcomes: those who belong to underserved minority groups, are less well educated, are younger at diagnosis, have conflicted relationships, and are made prematurely menopausal by adjuvant chemotherapy."
-end-
Contacts:
  • Article: Jean-François Huppé, Université Laval, 418-656-7785, Jean-Francois.Huppe@scom.ulaval.ca
  • Editorial: Laura Sussman, Communications Office, M. D. Anderson Cancer Center, 713-745-2457, lsussman@mdanderson.org

    Citations:
  • Article: Maunsell E, Drolet M, Brisson J, Brisson C, Mâsse B, Deschênes L. Work Situation After Breast Cancer: Results From a Population-Based Study. J Natl Cancer Inst 2004;96:1813-22.
  • Editorial: Schover LR. Myth-Busters: Telling the True Story of Breast Cancer Survivorship. J Natl Cancer Inst 2004;96:1800-01.

    Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oupjournals.org/.

    Journal of the National Cancer Institute

    Related Breast Cancer Articles from Brightsurf:

    Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
    The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

    Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
    New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

    Partial breast irradiation effective treatment option for low-risk breast cancer
    Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

    Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
    Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

    More clues revealed in link between normal breast changes and invasive breast cancer
    A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

    Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
    A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

    Computers equal radiologists in assessing breast density and associated breast cancer risk
    Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

    Blood test can effectively rule out breast cancer, regardless of breast density
    A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

    Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
    Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

    Young breast cancer patients undergoing breast conserving surgery see improved prognosis
    A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

    Read More: Breast Cancer News and Breast Cancer Current Events
  • Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.